Pharma ZEE Surl Pharmaceutical Import Profile — Tanzania (DGFT 2022–2026)

Name: Pharma ZEE Surl Pharmaceutical Import Records from India — 2 Products, $300.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Pharma ZEE Surl — Pharmaceutical Importer Profile (2026) | 2 Products, $300.0K Trade | TransData Nexus

Who Are the Verified Indian Suppliers to Pharma ZEE Surl?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Vansh Remedies	$1.4M	42	100.0%

Pharma ZEE Surl sources from 1 verified Indian supplier across 14 distinct formulations. The sourcing is highly concentrated — Vansh Remedies accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Pharma ZEE Surl Import?

Formulation	Value	Ships
Tini-van- tinidazole tablets BP 500 MG	$110.5K	3
Ibu-van - ibuprofen tablets BP 400 MG	$103.7K	3
Nyst-van- nystatin suspension 100000	$103.7K	3
Rectovan - anti haemorrhoidal	$103.5K	3
Indo-van - indometacine capsules 25 MG	$103.1K	3
Diclo-van -diclofenac sodium	$103.1K	3
Rhinovan-p - carbocisteine &	$102.9K	3
Stovan ointment - triamciolone	$102.7K	3
Stovan cream - triamciolone acetonide	$102.7K	3
Rhinovan-5 - carbocisteine syrup 5%

Pharma ZEE Surl imports 14 distinct pharmaceutical formulations. Showing top 14 by value. For full formulation-level data, contact TransData Nexus.

What Products Does Pharma ZEE Surl Import?

Top Products by Import Value

1Nystatin$150.0K 2Tinidazole$150.0K

Pharma ZEE Surl Therapeutic Categories — 2 Specializations

Pharma ZEE Surl imports across 2 therapeutic categories, with Antifungals (50.0%), Advanced Antibiotics (50.0%), representing the largest segments. The portfolio is concentrated — top 5 products = 100% of total imports.

Antifungals

1 products · 50.0% · $150.0K

Advanced Antibiotics

1 products · 50.0% · $150.0K

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Nystatin	Antifungals	$150.0K	3	0.3%	10
2	Tinidazole	Advanced Antibiotics	$150.0K	3	0.8%	1

Key Metrics

Total Import Value$300.0K

Products2

Shipments6

Categories2

CountryTanzania

#1 Rankings1

Indian Suppliers1

Formulations14

Top Categories

Antifungals50.0%

Advanced Antibiotics50.0%

Indian Suppliers

Last updated: March 28, 2026

Pharma ZEE Surl — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Pharma ZEE Surl is a pharmaceutical importer and buyer based in Tanzania, specializing in the acquisition of finished pharmaceutical formulations from India. The company has engaged in six shipments over the period from 2022 to 2026, with a total import value of $300,000 USD. These imports encompass two primary therapeutic categories: Antifungals and Advanced Antibiotics, each accounting for 50% of the portfolio. The top five products imported include Nystatin and Tinidazole, each valued at $150,000 USD, representing 0.3% and 0.8% market share respectively. Notably, Pharma ZEE Surl is the leading buyer of Tinidazole in the Tanzanian market. The company's sole verified Indian supplier is VANSH REMEDIES, which has provided all 42 shipments, amounting to $1.4 million USD. This indicates a high level of supplier concentration, with a portfolio comprising 14 unique formulations.

2Distribution Network

While specific details about Pharma ZEE Surl's warehouse locations and logistics capabilities are not publicly available, the company's import activities suggest a distribution network that effectively serves the Tanzanian market. The focus on finished pharmaceutical formulations indicates a streamlined supply chain designed to meet the needs of local healthcare providers. The reliance on a single supplier, VANSH REMEDIES, suggests a centralized procurement strategy, potentially facilitating efficient inventory management and distribution processes.

Importing Pharmaceuticals into Tanzania — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Tanzania

1Regulatory Authority & Framework

The Tanzania Medicines and Medical Devices Authority (TMDA) is the primary regulatory body overseeing the importation and exportation of pharmaceutical products in Tanzania. Established under the Tanzania Medicines and Medical Devices Act, Cap. 219, TMDA is responsible for ensuring the safety, efficacy, and quality of medicines and medical devices. Key legislation governing pharmaceutical imports includes the Pharmaceutical and Poisons Act, which outlines the control of manufacture, sale, import, and export of pharmaceutical products. The registration of pharmaceutical products is mandated under these regulations, requiring importers to obtain appropriate licenses and ensure compliance with established standards.

2Import Licensing & GMP

Importers of pharmaceutical products in Tanzania must obtain a valid import license from TMDA. The application process involves submitting necessary documents and paying the prescribed fees. Importers are also required to register their premises with TMDA and ensure compliance with Good Manufacturing Practice (GMP) standards. GMP certification from recognized authorities, such as the World Health Organization (WHO), is essential for the importation of pharmaceutical products. Additionally, importers must adhere to labeling requirements, including the use of the English language and compliance with TMDA's guidelines. (tmda.go.tz)

3Quality & Labeling

Imported pharmaceutical products must undergo batch testing to ensure quality and safety. Stability requirements are set to guarantee the efficacy of products throughout their shelf life. Labeling must be in English and include all necessary information as prescribed by TMDA, such as product name, active ingredients, dosage form, and storage conditions. Serialization mandates may be implemented to enhance traceability and prevent counterfeit products. Importers are responsible for ensuring that all products meet these quality and labeling standards before distribution. (tmda.go.tz)

4Recent Regulatory Changes

Between 2024 and 2026, TMDA has implemented several policy changes affecting pharmaceutical imports into Tanzania. These include stricter enforcement of GMP certification requirements, updated labeling standards to enhance product traceability, and revised import permit application procedures to streamline the approval process. Importers are advised to stay informed about these changes to ensure compliance and maintain uninterrupted supply chains. (tmda.go.tz)

TransData Nexus Research · Tanzania regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Buyer Matching: Pharma ZEE Surl identified across shipments using consignee name normalization.
2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
3.Market Share: Calculated per product as Pharma ZEE Surl's capped value divided by total Indian exports for that product.
4.Shipment Count: Based on 6 individual customs records matching Pharma ZEE Surl.
5.Supplier Verification: Pharma ZEE Surl sources from 1 verified Indian suppliers across 14 formulations, confirmed from customs records.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2 Products Tracked

2 therapeutic categories

Expert-Reviewed

By pharmaceutical trade specialists

Pharma ZEE Surl

Pharma ZEE Surl — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Pharma ZEE Surl?

What Formulations Does Pharma ZEE Surl Import?

What Products Does Pharma ZEE Surl Import?

Top Products by Import Value

Pharma ZEE Surl Therapeutic Categories — 2 Specializations

Import Portfolio — Top 2 by Import Value

Key Metrics

Top Categories

Indian Suppliers

Pharma ZEE Surl — Corporate Profile & Information

1Company Overview

2Distribution Network

Related Trade Data

Need Detailed Data?

3Industry Role

Supplier Relationship Intelligence — Pharma ZEE Surl

1Sourcing Concentration Analysis

2Supply Chain Resilience

3Strategic Implications

Importing Pharmaceuticals into Tanzania — Regulatory Framework

1Regulatory Authority & Framework

2Import Licensing & GMP

3Quality & Labeling

4Recent Regulatory Changes

Pharma ZEE Surl — Procurement Pattern Analysis

1Product Strategy

2Sourcing Profile

3Market Positioning

Seller's Guide — How to Become a Supplier to Pharma ZEE Surl

1Opportunity Assessment

2Requirements & Qualifications

3How to Approach

Frequently Asked Questions — Pharma ZEE Surl

What products does Pharma ZEE Surl import from India?

Who supplies pharmaceuticals to Pharma ZEE Surl from India?

What is Pharma ZEE Surl's total pharmaceutical import value?

What therapeutic categories does Pharma ZEE Surl focus on?

Get Full Pharma ZEE Surl Import Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Data Source & Methodology